Tau phosphorylation, aggregation, and cell toxicity

Journal of Biomedicine and Biotechnology

Volumn 2006, Issue , 2006, Pages

  Avila, J ^a   Santa Maria I ^a   Perez M ^a   Hernandez F ^a   Moreno, F ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; ATAXIN 1; ATAXIN 3; HUNTINGTIN; NEUROFILAMENT PROTEIN; PRION PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; LEWY BODY; MACHADO JOSEPH DISEASE; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PRION DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; REVIEW; SPINOCEREBELLAR DEGENERATION;

EID: 33646083011     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/JBB/2006/74539     Document Type: Review

References (57)

1. S B Prusiner Shattuck lecture - neurodegenerative diseases and prions. The New England Journal of Medicine 344 2001 20 1516 1526 11357156
2. M Sadqi F Hernández U Pan Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. Biochemistry 41 2002 22 7150 7155 12033949
3. M Arrasate S Mitra E S Schweitzer M R Segal S Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 2004 7010 805 810 15483602
4. V T Marchesi An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 102 2005 26 9093 9098 15967987
5. N F Bence R M Sampat R R Kopito Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 2001 5521 1552 1555 11375494
6. G Merlini V Bellotti Molecular mechanisms of amyloidosis. The New England Journal of Medicine 349 2003 6 583 596 12904524
7. C A Ross M A Poirier Protein aggregation and neurodegenerative disease. Nature Medicine 10 2004 suppl S10 S17 15272267
8. J Avila J J Lucas M Pérez F Hernández Role of tau protein in both physiological and pathological conditions. Physiological Reviews 84 2004 2 361 384 15044677
9. R A Crowther O F Olesen R Jakes M Goedert The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease. FEBS Letters 309 1992 2 199 202 1505683
10. E Montejo de Garcini L Serrano J Avila Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease. Biochemical and Biophysical Research Communications 141 1986 2 790 796 3099793
11. M Pérez J M Valpuesta M Medina E Montejo de Garcini J Avila Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. Journal of Neurochemistry 67 1996 3 1183 1190 8752125
12. H Wille G Drewes J Biernat E M Mandelkow E Mandelkow Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. The Journal of Cell Biology 118 1992 3 573 584 1639844
13. I Santa-María F Hernández M A Smith G Perry J Avila F J Moreno Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers. Molecular and Cellular Biochemistry 278 2005 1-2 203 212 16180106
14. W M van Roon-Mom S J Reid R L Faull R G Snell TATA-binding protein in neurodegenerative disease. Neuroscience 133 2005 4 863 872 15916858
15. D C David R Layfield L Serpell Y Narain M Goedert M G Spillantini Proteasomal degradation of tau protein. Journal of Neurochemistry 83 2002 1 176 185 12358741
16. N Sahara M Murayama T Mizoroki In vivo evidence of CHIP up-regulation attenuating tau aggregation. Journal of Neurochemistry 94 2005 5 1254 1263 16111477
17. G V Johnson R S Jope L I Binder Proteolysis of tau by calpain. Biochemical and Biophysical Research Communications 163 1989 3 1505 1511 2551295
18. H Shimura D Schwartz S P Gygi K S Kosik CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. The Journal of Biological Chemistry 279 2004 6 4869 4876 14612456
19. P J Kahle C Haass How does parkin ligate ubiquitin to Parkinson's disease? EMBO Reports 5 2004 7 681 685 15229644
20. M S Gentry C A Worby J E Dixon Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proceedings of the National Academy of Sciences of the United States of America 102 2005 24 8501 8506 15930137
21. T C Gamblin R W Berry L I Binder Tau polymerization: role of the amino terminus. Biochemistry 42 2003 7 2252 2257 12590615
22. T C Gamblin R W Berry L I Binder Modeling tau polymerization in vitro: a review and synthesis. Biochemistry 42 2003 51 15009 15017 14690409
23. T C Gamblin M E King H Dawson In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. Biochemistry 39 2000 20 6136 6144 10821687
24. T C Gamblin M E King J Kuret R W Berry L I Binder Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39 2000 46 14203 14210 11087369
25. I Grundke-Iqbal K Iqbal Y C Tung M Quinlan H M Wisniewski L I Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences of the United States of America 83 1986 13 4913 4917 3088567
26. M D Ledesma P Bonay C Colaço J Avila Analysis of microtubule-associated protein tau glycation in paired helical filaments. The Journal of Biological Chemistry 269 1994 34 21614 21619 8063802
27. C M Wischik R YK Lai C R Harrington J Avila R Brandt K S Kosik Modelling prion-like processing of tau protein in Alzheimer's disease for pharmaceutical development. Brain Microtubule Associated Proteins: Modification in Disease Harwood Academic Chur, Switzerland 1997 185 241
28. M Pérez M Arrasate E Montejo de Garcini V Munoz J Avila In vitro assembly of tau protein: mapping the regions involved in filament formation. Biochemistry 40 2001 20 5983 5991 11352733
29. I Santa-María F Hernández C P Martin J Avila F J Moreno Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 43 2004 10 2888 2897 15005624
30. W Noble E Planel C Zehr Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America 102 2005 19 6990 6995 15867159
31. M Pérez F Hernández F Lim J Diaz-Nido J Avila Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. Journal of Alzheimer's Disease 5 2003 4 301 308 14624025
32. I E Vega L Cui J A Propst M L Hutton G Lee S H Yen Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Brain Research. Molecular Brain Research 138 2005 2 135 144 15913839
33. K Duff E Planel Untangling memory deficits. Nature Medicine 11 2005 8 826 827 16079873
34. F Lim F Hernández J J Lucas P Gomez-Ramos M A Moran J Avila FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Molecular and Cellular Neuroscience 18 2001 6 702 714 11749044
35. F Hernández R Cuadros J Avila Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers. Neuroscience Letters 357 2004 2 143 146 15036595
36. M A Lovell W R Markesbery Ectopic expression of Musashi-1 in Alzheimer disease and Pick disease. Journal of Neuropathology and Experimental Neurology 64 2005 8 675 680 16106215
37. P J Lu G Wulf X Z Zhou P Davies K P Lu The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399 1999 6738 784 788 10391244
38. M Poli L B Gatta R Dominici DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease. Neuroscience Letters 389 2005 2 66 70 16095818
39. V M Lee M Goedert J Q Trojanowski Neurodegenerative tauopathies. Annual Review of Neuroscience 24 2001 1121 1159 11520930
40. S C Feinstein L Wilson Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. Biochimica et Biophysica Acta 1739 2005 2-3 268 279 15615645
41. M Goedert S Satumtira R Jakes Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. Journal of Neurochemistry 75 2000 5 2155 2162 11032905
42. R Brandt M Hundelt N Shahani Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochimica et Biophysica Acta 1739 2005 2-3 331 354 15615650
43. C Andorfer C M Acker Y Kress P R Hof K Duff P Davies Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. The Journal of Neuroscience 25 2005 22 5446 5454 15930395
44. H G Lee G Perry P I Moreira Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends in Molecular Medicine 11 2005 4 164 169 15823754
45. P V Arriagada J H Growdon E T Hedley-Whyte B T Hyman Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42 1992 3 pt 1 631 639 1549228
46. H Braak E Braak Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica (Berl) 82 1991 4 239 259 1759558
47. A Alzheimer Über eigenartige Krankheitsfälle des späteren Alters. Zeitschrift für die gesamte Neurologie und Psychiatrie 4 1911 356 385
48. P Cras M A Smith P L Richey S L Siedlak P Mulvihill G Perry Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathologica (Berl) 89 1995 4 291 295 7610759
49. Y Fukutani K Kobayashi I Nakamura K Watanabe K Isaki N J Cairns Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neuroscience Letters 200 1995 1 57 60 8584267
50. W Bondareff C Q Mountjoy M Roth D L Hauser Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiology of Aging 10 1989 6 709 715 2628782
51. M Goedert Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 354 1999 1386 1101 1118 10434313
52. R Morsch W Simon P D Coleman Neurons may live for decades with neurofibrillary tangles. Journal of Neuropathology and Experimental Neurology 58 1999 2 188 197 10029101
53. K Santacruz J Lewis T Spires Tau suppression in a neurodegenerative mouse model improves memory function. Science 309 2005 5733 476 481 16020737
54. B Caughey P T Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annual Review of Neuroscience 26 2003 267 298 12704221
55. T D Bird D Nochlin P Poorkaj A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 122 1999 pt 4 741 756 10219785
56. A Delacourte J P David N Sergeant The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52 1999 6 1158 1165 10214737
57. T Gomez-Isla R Hollister H West Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Annals of Neurology 41 1997 1 17 24 9005861